Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chander, P. N.
Right arrow Articles by Stier, C. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chander, P. N.
Right arrow Articles by Stier, C. T., Jr.
J Am Soc Nephrol 14:1990-1997, 2003
© 2003 American Society of Nephrology

Aldosterone Plays a Pivotal Role in the Pathogenesis of Thrombotic Microangiopathy in SHRSP

Praveen N. Chander*, Ricardo Rocha{dagger}, Jeffrey Ranaudo{dagger}, Gagan Singh{dagger}, Andrea Zuckerman{ddagger} and Charles T. Stier, Jr.{dagger}

Departments of *Pathology, {dagger}Pharmacology, and {ddagger}Pediatrics, New York Medical College, Valhalla, New York.

Correspondence to Dr. Praveen N. Chander, Department of Pathology, Basic Science Building, New York Medical College, Valhalla, NY 10595; Phone: 914-594-4172; Fax: 914-594-4161;

ABSTRACT. Angiotensin-converting enzyme inhibitors and aldosterone receptor antagonists ameliorate malignant nephrosclerotic lesions of thrombotic microangiopathy in salt-loaded, stroke-prone, spontaneously hypertensive rats (SHRSP) without controlling hypertension. This suggests that angiotensin II (Ang II) and/or aldosterone (ALDO) plays a critical role in renal injury in this model. For evaluating their relative roles in the pathogenesis of thrombotic microangiopathy, SHRSP were adrenalectomized and infused with vehicle, Ang II, or ALDO or were sham-operated for adrenalectomy (SHAM). Saline-drinking rats were assigned to one of four groups: SHAM, adrenalectomy, adrenalectomy + Ang II (25 ng/min, subcutaneously), or adrenalectomy + ALDO (40 µg/kg per d, subcutaneously). All SHRSP received dexamethasone (12 µg/kg per d, subcutaneously). Adrenalectomy did not show changes in body weight, plasma creatinine, sodium and potassium, and daily urinary sodium and potassium excretion; did not prevent hypertension but prevented proteinuria (12 ± 1 versus 49 ± 3 mg/d; P < 0.01); and abrogated thrombotic microangiopathy and decreased plasma aldosterone (<16 versus 710 ± 91 pg/ml; P < 0.001) compared with SHAM. Systolic BP in adrenalectomy + Ang II and adrenalectomy + ALDO (238 ± 8 and 241 ± 9 mmHg, respectively) was similar to SHAM. Despite Ang II infusion, proteinuria (17 ± 9 mg/d) and thrombotic microangiopathy and plasma aldosterone (18 ± 18 pg/ml) remained low but daily urinary excretion of sodium and potassium were not different from adrenalectomy + ALDO. Adrenalectomy + ALDO showed plasma aldosterone levels of 735 ± 147 pg/ml; plasma potassium was lower; plasma creatinine and proteinuria (78 ± 7 mg/d) were greater and thrombotic microangiopathy lesions were comparable to SHAM. These results demonstrate a pivotal role for aldosterone in the development of thrombotic microangiopathy, independent of hypertension. E-mail: praveen_chander@NYMC.edu




This article has been cited by other articles:


Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
T.-Y. Chun, P. N. Chander, J.-W. Kim, J. H. Pratt, and C. T. Stier Jr.
Aldosterone, but not angiotensin II, increases profibrotic factors in kidney of adrenalectomized stroke-prone spontaneously hypertensive rats
Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E305 - E312.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Pathol.Home page
B Rayner
Primary aldosteronism and aldosterone-associated hypertension
J. Clin. Pathol., July 1, 2008; 61(7): 825 - 831.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
S. Sethi, S. Iida, C. D. Sigmund, and D. D. Heistad
Renal Thrombotic Microangiopathy in a Genetic Model of Hypertension in Mice
Experimental Biology and Medicine, February 1, 2006; 231(2): 196 - 203.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
K. Miyata, M. Rahman, T. Shokoji, Y. Nagai, G.-X. Zhang, G.-P. Sun, S. Kimura, T. Yukimura, H. Kiyomoto, M. Kohno, et al.
Aldosterone Stimulates Reactive Oxygen Species Production through Activation of NADPH Oxidase in Rat Mesangial Cells
J. Am. Soc. Nephrol., October 1, 2005; 16(10): 2906 - 2912.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
A. Fiebeler, J. Nussberger, E. Shagdarsuren, S. Rong, G. Hilfenhaus, N. Al-Saadi, R. Dechend, M. Wellner, S. Meiners, C. Maser-Gluth, et al.
Aldosterone Synthase Inhibitor Ameliorates Angiotensin II-Induced Organ Damage
Circulation, June 14, 2005; 111(23): 3087 - 3094.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
R. Sepehrdad, P. N. Chander, G. Singh, and C. T. Stier Jr
Sodium transport antagonism reduces thrombotic microangiopathy in stroke-prone spontaneously hypertensive rats
Am J Physiol Renal Physiol, June 1, 2004; 286(6): F1185 - F1192.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673